Skip to content

The Tower Post

  • Economy
  • International
  • Politics
  • War
  • Technology
  • Style
  • Sport

Biotech

  • A New Kind of CAR-T Therapy Shows Early Promise Against Multiple Sclerosis
    September 9, 2026

    A New Kind of CAR-T Therapy Shows Early Promise Against Multiple Sclerosis

    Editorial Staff
  • EU Tightens the Screws on Housing and Biotech
    December 19, 2025

    EU Tightens the Screws on Housing and Biotech

    Editorial Staff
  • Corporate Crypto Rush: 150+ Companies Buy Digital Assets to Boost Stock Prices
    August 14, 2025

    Corporate Crypto Rush: 150+ Companies Buy Digital Assets to Boost Stock Prices

    Editorial Staff
  • Eli Lilly Eyes $1.3B Acquisition of Verve Therapeutics
    June 22, 2025

    Eli Lilly Eyes $1.3B Acquisition of Verve Therapeutics

    Editorial Staff
  • Sanofi’s $9.5B Bid: Blueprint Medicines Set for Major Acquisition
    June 5, 2025

    Sanofi’s $9.5B Bid: Blueprint Medicines Set for Major Acquisition

    Editorial Staff
  • BioMarine Acquires Inozyme for $270 Million in Strategic Biotech Move
    May 21, 2025

    BioMarine Acquires Inozyme for $270 Million in Strategic Biotech Move

    Editorial Staff
  • Market Value of NewLimit Biotech
    May 12, 2025

    Market Value of NewLimit Biotech

    Editorial Staff

Categories

  • Economy
  • International
  • Politics
  • Sport
  • Style
  • Technology
  • War
Loading Comments...